Kevin Gatter | Academic Influence

Q: What Schools Are Affiliated With Kevin Gatter

Kevin Gatter is affiliated with the following schools: University of Oxford, KU Leuven, Charing Cross Hospital Medical School

Why Is Kevin Gatter Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kevin Gatter was an English pathologist who created a technique for identifying the source of cancer in the human body. Gatter was the Head of the Department of Cellular Science at St John's College, Oxford and an internationally recognized expert in haematopathology.

(See a Problem?)

Kevin Gatter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. (1994) (6264)
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. (1985) (1836)
Increased expression of mutant forms of p53 oncogene in primary lung cancer (1990) (1113)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages (2000) (1112)
Transferrin receptor on endothelium of brain capillaries (1984) (952)
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. (1998) (686)
Monoclonal antibody Ki‐67: its use in histopathology (1990) (669)
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. (1990) (647)
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. (1994) (629)
bcl-2 protein in non-small-cell lung carcinoma. (1993) (607)
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases (2002) (586)
Transferrin receptors in human tissues: their distribution and possible clinical relevance. (1983) (539)
Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data (1992) (516)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival (2001) (513)
Ki67 protein: the immaculate deception? (2002) (506)
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. (1989) (483)
Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis (1995) (479)
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. (1990) (443)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. (2001) (431)
Immunocytochemical localization of the cystic fibrosis gene product CFTR. (1991) (422)
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. (1983) (370)
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. (1988) (344)
The Bloom's Syndrome Gene Product Interacts with Topoisomerase III* (2000) (333)
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. (2002) (325)
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. (2002) (319)
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. (2002) (282)
HUMAN LYMPHOID CELLS EXPRESS EPITHELIAL MEMBRANE ANTIGEN Implications for Diagnosis of Human Neoplasms (1984) (280)
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. (2001) (268)
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. (2002) (267)
The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. (2001) (262)
Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. (1999) (260)
TUMOUR ANGIOGENESIS (1996) (243)
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? (2013) (236)
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. (1990) (230)
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression (2004) (229)
Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. (1992) (223)
Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. (1992) (220)
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy (2012) (214)
Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. (1985) (214)
Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. (1995) (210)
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. (1993) (207)
Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. (2006) (206)
Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma (2002) (201)
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. (2005) (200)
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. (2003) (195)
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. (1996) (191)
Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study (1995) (189)
REARRANGEMENT OF THE T-CELL-RECEPTOR β-CHAIN GENE IN THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISORDERS (1985) (188)
PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER (1996) (187)
Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. (1989) (186)
Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis (2003) (185)
New sites of human S-100 immunoreactivity detected with monoclonal antibodies. (1986) (183)
The organization of the connections between the cortex and the claustrum in the monkey (1982) (181)
Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. (1989) (180)
A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. (1995) (179)
Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. (1986) (178)
Expression of mutant p53 in melanoma. (1991) (175)
Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer (2002) (172)
Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease (2003) (171)
The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. (2010) (170)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin (2003) (167)
The relationship of p53 immunostaining to survival in carcinoma of the lung. (1992) (166)
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. (1986) (164)
Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. (1998) (164)
Malignant histiocytosis a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies (1990) (163)
Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. (1994) (159)
The immunocytochemical detection of axillary micrometastases in breast cancer. (1984) (149)
Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. (1985) (146)
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma (2003) (142)
An immunohistochemical study of differentiation in malignant fibrous histiocytoma (1987) (140)
Plasmablastic lymphoma in HIV+ patients: an expanding spectrum (2003) (136)
Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. (1997) (135)
CLINICAL IMPORTANCE OF ANALYSING MALIGNANT TUMOURS OF UNCERTAIN ORIGIN WITH IMMUNOHISTOLOGICAL TECHNIQUES (1985) (132)
Retrograde cell degeneration in the basal nucleus in monkey and man (1983) (128)
Expression of hypoxia‐inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas (2005) (125)
[Heterogeneous Epstein-Barr virus infection patterns in peripheral T cell lymphoma of the angioimmunoblastic lymphadenopathy type]. (1992) (124)
BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer (2004) (124)
An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat. (1980) (123)
Genotypic analysis of large cell lymphomas which express the Ki‐1 antigen (1987) (122)
Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. (2002) (121)
Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines (2015) (121)
Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. (1992) (121)
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. (2010) (120)
Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy (2011) (120)
The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction (1990) (117)
LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. (2010) (116)
New approach to assessing lung tumours in man. (1986) (111)
Co‐expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma (1998) (110)
Granular cell tumours revisited. An immunohistological and ultrastructural study (1988) (109)
Skin Lymphoma: The Illustrated Guide (2009) (108)
Role of Hypoxia‐Inducible Factors in Epigenetic Regulation via Histone Demethylases (2009) (106)
Langerhans’cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia (1983) (105)
Epithelial membrane antigen expression by the perineurium of peripheral nerve and in peripheral nerve tumours (1988) (105)
The angiogenic pathway ‘vascular endothelial growth factor/flk‐1(KDR)‐receptor’ in rheumatoid arthritis and osteoarthritis (2001) (105)
The projection of the basal nucleus of Meynert upon the neocortex in the monkey (1983) (104)
Non-angiogenic tumours and their influence on cancer biology (2018) (104)
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype (2013) (104)
Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. (2002) (103)
Langerhans' cells and T cells in human skin tumours: an immunohistological study (1984) (102)
CD30 expression in non‐Hodgkin's lymphoma (1990) (102)
The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers (2004) (98)
Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. (1986) (98)
Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas (2010) (98)
Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. (1992) (97)
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin–Reed–Sternberg cells in Hodgkin's disease (2002) (97)
Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. (1989) (97)
Ki‐67 immunostaining and survival in operable lung cancer (1991) (95)
Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma (1999) (94)
An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. (1986) (93)
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. (2006) (91)
Human lung tumours may coexpress different classes of intermediate filaments. (1986) (90)
BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions in In situ Versus Invasive Cancer (2007) (90)
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) (1994) (88)
DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancer (2003) (87)
Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors (2008) (87)
Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer (2005) (87)
Expression of VEGF in routinely fixed material using a new monoclonal (1998) (87)
The intrinsic connections of the cortex of area 4 of the monkey. (1978) (86)
Anaplastic large‐cell lymphomas of B‐cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B‐cell lymphomas (2000) (86)
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. (2008) (86)
An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel (1984) (86)
Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. (1986) (86)
Low-Dose IFN-γ Induces Tumor MHC Expression in Metastatic Malignant Melanoma (2003) (85)
Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer. (2015) (83)
Certain connections of the visual cortex of the monkey shown by the use of horseradish peroxidase (1975) (82)
The angiogenic “vascular endothelial growth factor/flk‐1(KDR) receptor” pathway in patients with endometrial carcinoma (2001) (82)
Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. (1985) (82)
VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. (1994) (80)
CD44 and cancer screening (1993) (80)
Validation of anti‐vascular endothelial growth factor (anti‐VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium (1998) (80)
Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues. (1987) (79)
Autophagy and lysosomal related protein expression patterns in human glioblastoma (2014) (79)
Evidence for novel non-angiogenic pathway in breast-cancer metastasis (2000) (76)
Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray (2004) (75)
Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation (1990) (74)
Hypoxia and activated VEGF/receptor pathway in multiple myeloma. (2010) (74)
CITED4 Inhibits Hypoxia-Activated Transcription in Cancer Cells, and Its Cytoplasmic Location in Breast Cancer Is Associated with Elevated Expression of Tumor Cell Hypoxia-Inducible Factor 1α (2004) (72)
Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non‐Hodgkin's lymphoma (2002) (72)
c-erbB-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α Dependent (2004) (72)
Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. (1988) (71)
The projection of the locus coeruleus upon the neocortex in the macaque monkey (1977) (71)
p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON‐HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS (1997) (71)
Anaplastic Large‐Cell Lymphoma (2011) (70)
Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies (1984) (70)
Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. (2006) (70)
CD3: Structure, function, and role of immunostaining in clinical practice (1994) (69)
A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. (1986) (66)
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer (2006) (65)
Plasmablastic lymphomas may occur as post‐transplant lymphoproliferative disorders (2007) (65)
Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67 (1993) (65)
Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. (1998) (65)
Loss of HLA class‐I alleles, heavy chains and β2‐microglobulin in colorectal cancer (1992) (64)
Effects of HIF-1α and HIF2α on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts (2010) (64)
Splenic B‐Cell Marginal Zone Lymphoma (2011) (63)
Advances in Brief Hypoxia-inducible Factors HIF-1 and HIF-2 in Head and Neck Cancer : Relationship to Tumor Biology and Treatment Outcome in Surgically Resected Patients (2002) (62)
What is the value of bcl‐2 protein detection for histopathologists? (1995) (62)
TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC (2014) (62)
EARLY EXPRESSION OF bcl‐2 PROTEIN IN THE ADENOMA–CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA (1996) (62)
Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. (1988) (61)
Osteoclasts contain macrophage and megakaryocyte antigens (1986) (61)
The hypoxia‐regulated transcription factor DEC1 (Stra13, SHARP‐2) and its expression in human tissues and tumours (2004) (60)
Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. (1989) (60)
A study of adhesion molecules as markers of progression in malignant melanoma (1992) (60)
A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues. (1983) (60)
CELL LINEAGE IN HODGKIN'S DISEASE (1987) (59)
Atrial fibrillation is associated with cardiac hypoxia. (2010) (59)
Potential role of bcl‐2 as a suppressor of tumour angiogenesis in non‐small‐cell lung cancer (1997) (59)
‘Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non‐small cell lung cancer (2000) (59)
Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus (2004) (57)
Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma. (2003) (57)
Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. (1987) (57)
Langerhans’cells in human cervical epithelium: an immunohistological study (1983) (57)
Lymphoma classification proposal: clarification. (1995) (57)
Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens. (1988) (57)
Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. (1988) (56)
Gene rearrangements in T‐cell lymphoblastic lymphoma (1999) (55)
Platelet‐derived endothelial cell growth factor (Thymidine Phosphorylase) expression in lung cancer (1997) (55)
The cortical relationships of certain basal ganglia and the cholinergic basal forebrain nuclei (1983) (54)
Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1α expression (2006) (54)
Angiogenic co‐operation of VEGF and stromal cell TP in endometrial carcinomas (2002) (53)
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells (1987) (53)
CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. (2012) (52)
Diffuse large B-cell lymphoma (2010) (52)
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer (2007) (51)
Plasminogen activator inhibitor‐1 as a measure of vascular remodelling in breast cancer (2001) (51)
The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. (1985) (50)
Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. (2004) (50)
Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. (2007) (50)
An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. (1993) (49)
Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma (2011) (49)
bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer (2004) (48)
Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high‐grade non‐Hodgkin's lymphoma (1995) (48)
FREEZE-DRIED PARAFFIN-EMBEDDED HUMAN TISSUE FOR ANTIGEN LABELLING WITH MONOCLONAL ANTIBODIES (1984) (47)
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. (2010) (47)
Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases (2011) (47)
Heterogeneity of bcl‐2 expression in MALT lymphoma (1995) (47)
Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. (1995) (46)
Expression of the p53 protein in a spectrum of astrocytic tumours (1992) (46)
The expression of the CD3 antigen in Hodgkin's disease (1989) (46)
Nuclear localization of human AP endonuclease 1 (HAP1/Ref‐1) associates with prognosis in early operable non‐small cell lung cancer (NSCLC) (1999) (45)
Lymphoproliferative disorders in Oxford renal transplant recipients (2003) (45)
Lymphoid Proliferations of Indeterminate Malignant Potential arising in Adults with Common Variable Immunodeficiency Disorders: Unusual Case Studies and Immunohistological Review in the Light of Possible Causative Events (2011) (45)
The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas (1989) (44)
Langerhans' cells in human cervical epithelium: an immunohistological study. (1984) (44)
Angiogenin is up‐regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival (2005) (43)
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. (2004) (43)
p53 Antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: Relationship to hpv infection and integration (1993) (42)
Detection of NPM‐ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma (1995) (42)
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. (1984) (42)
Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis (2006) (41)
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. (2006) (41)
Expression of the Ig‐associated heterodimer (mb‐1 and B29) in Hodgkin's disease (1993) (41)
Expression of intermediate filament proteins in normal and diseased thyroid glands. (1987) (41)
Phosphorylated VEGFR2/KDR receptors are widely expressed in B‐cell non‐Hodgkin's lymphomas and correlate with hypoxia inducible factor activation (2008) (40)
Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells (2010) (40)
Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer (1999) (40)
The bone marrow trephine biopsy: a review of normal histology (1993) (40)
Phosphorylated KDR can be located in the nucleus of neoplastic cells (2006) (39)
BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosis (2007) (38)
NB84: A new monoclonal antibody for the recognition of neuroblastoma in routinely processed material (1991) (38)
An electron microscopic study of retrograde and orthograde transport of horseradish peroxidase to the lateral geniculate nucleus of the monkey (1975) (38)
T‐cell origin of Lennert's lymphoma (1986) (38)
Immunohistochemical study of mammary and extra‐mammary Paget's disease (1984) (38)
Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides. (1986) (37)
Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. (1992) (37)
Epithelial membrane antigen in hematopoietic neoplasms. (1986) (37)
Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma (2003) (36)
Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. (1988) (36)
Cellular distribution of human leucocyte adhesion molecule ICAM-3. (1994) (35)
Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours (2014) (35)
ICAM-3 expression on endothelium in lymphoid malignancy. (1993) (35)
Breast cancer angiogenesis and tamoxifen resistance (1995) (34)
Association between platelet microthrombi and finger clubbing (1991) (34)
Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer (2005) (34)
An immunohistological study of benign and skin tumours: epithelial aspects (1984) (33)
Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. (1990) (33)
Is it necessary to embed bone marrow biopsies in plastic for haematological diagnosis? (1987) (33)
Immunophenotyping of acute myeloid leukemia by immuno‐alkaline phosphatase (APAAP) labeling with a panel of antibodies (1987) (32)
The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells (2001) (31)
Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates. (1986) (31)
Primary Hodgkin's disease of the lung (1995) (31)
Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting (2005) (31)
Incidence, management, and outcome of high‐grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long‐term outcomes from a 30‐year experience (2015) (30)
The FOXP 1 Winged Helix Transcription Factor Is a Novel Candidate Tumor Suppressor Gene on Chromosome 3 p 1 (2001) (30)
Proliferative glomerulonephritis associated with mantle cell lymphoma--natural history and effect of treatment in 2 cases. (2004) (30)
An electron microscopic study of the termination of intracortical axons upon Betz cells in area 4 of the monkey. (1978) (30)
Langerhans cells in human lung tumours: an immunohistological study (1989) (30)
Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity? (2000) (30)
CD 30 expression in follicular lymphoma (1991) (29)
Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. (1992) (28)
Best Practice in Lymphoma Diagnosis and Reporting (2012) (28)
An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions. (1997) (27)
Primary cutaneous large cell CD30+ lymphoma in a renal transplant recipient (2003) (27)
CD68 reactivity of non-macrophage derived tumours in cytological specimens. (1993) (27)
Biochemical evidence that cytokeratins are present in smooth muscle. (1988) (27)
Thymidine phosphorylase expression in endometrial carcinomas (1999) (27)
Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. (1992) (27)
The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein. (1997) (26)
Giant cell myocarditis associated with lymphoma: an immunocytochemical study. (1987) (26)
Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions (2006) (25)
Practical value of genotypic analysis for diagnosing lymphoproliferative disorders. (1987) (25)
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. (1987) (25)
Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study. (2005) (25)
Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. (1995) (24)
DETECTION OF 14;18 CHROMOSOMAL TRANSLOCATION IN PARAFFIN-EMBEDDED LYMPHOMA TISSUE (1989) (24)
Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates (2004) (24)
Diagnostic immunocytochemistry: Achievements and challenges (1989) (22)
Cervical wart virus infection, intraepithelial neoplasia and carcinoma; an immunohistological study using a panel of monoclonal antibodies (1983) (22)
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins (2008) (22)
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM) (2016) (21)
Bone Marrow Diagnosis: An Illustrated Guide (2006) (21)
Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract. (1988) (21)
Nuclear and membrane expression of the angiogenesis regulator delta‐like ligand 4 (DLL4) in normal and malignant human tissues (2009) (21)
COMMENT ON: TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST CARCINOMA. AUTHORS' REPLY (1995) (21)
Dendritic reticulum cells in reactive lymph nodes and tonsils: an immunohistological study (1986) (21)
TAL‐1 protein expression in vascular lesions (1997) (20)
Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections. (1990) (20)
Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma. (1995) (20)
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. (2008) (20)
Immunohistochemical Analysis of Monoclonal Anti-B Cell Antibodies (1986) (19)
p53 expression in normal paraffin‐embedded tissue using different antibodies and antigen retrieval buffer systems (2003) (19)
Does nodular lymphocyte predominant Hodgkin's disease arise from progressively transformed germinal centres? A case report with an unusually prolonged history (1987) (19)
Monoclonal antibody JC1: new reagent for studying cell proliferation. (1992) (19)
Non‐angiogenic tumours unveil a new chapter in cancer biology (2015) (18)
bcl‐2 PROTEIN IS STRONGLY EXPRESSED IN POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (1996) (18)
Heterogeneity of CD3 antigen expression in T‐cell lymphoma (1993) (18)
Relationship of the K-ras/c-mos Expression Patterns With Angiogenesis in Non-Small Cell Lung Carcinomas (2001) (17)
High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC) (2013) (17)
Which antibodies for diagnostic pathology? (1987) (16)
Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression. (1996) (16)
SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study. (1995) (16)
NOT ANOTHER LYMPHOMA CLASSIFICATION! (1995) (16)
Blood vessels and cancer much more than just angiogenesis (2015) (16)
Why some tumours trigger neovascularisation and others don’t: the story thus far (2016) (16)
Skin Lymphoma: The Illustrated Guide: Cerroni/Skin Lymphoma: The Illustrated Guide (2009) (15)
Subcutaneous “Panniculitis‐Like” T‐Cell Lymphoma (2010) (15)
Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas (2002) (15)
Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation (1998) (15)
Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer (2004) (15)
Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas (2004) (14)
Breast cancer angiogenesis: therapy target and prognostic factor. (1995) (14)
A Study of Suicide Autopsies 1957–1977 (1980) (14)
Immunocytochemical Characterization of Monoclonal Anti-Leucocyte Antibodies (1984) (13)
BNIP 3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non – Small Cell Lung Cancer (2004) (13)
Epithelial membrane antigen expression by meningiomas, and the perineurium of peripheral nerve. (1987) (13)
The Value of Immunocytochemistry in Differentiating High-Grade: Lymphoma from Other Anaplastic Tumours: A study of anaplastic tumours from 1940 to 1960. (1989) (13)
Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas. (2013) (13)
Outcome in Non-Small Cell Lung Cancer Relates to Angiogenic Pathways and Independently to Poor Expression of Hypoxia-inducible Carbonic Anhydrase-9 Updated Version (2001) (12)
Platelet-derived endothelial cell growth factor/thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies. (1997) (12)
Bone Marrow Diagnosis (2006) (12)
Immunohistological recognition of cyclin D1 expression by non‐lymphoid cells among lymphoid neoplastic cells (2014) (12)
Role of immunohistochemistry in diagnosis of nasopharyngeal tumours. (1985) (12)
The characterization of two monoclonal anti‐keratin antibodies and their use in the study of epithelial disorders (1985) (12)
The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumours. (1985) (12)
Large B-Cell Lymphoma, Leg Type (2004) (12)
The use of monoclonal antibodies for histopathologic diagnosis of human malignancy. (1982) (11)
Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival (2011) (11)
AN IMMUNOHISTOCHEMICAL STUDY OF TAL‐1 PROTEIN EXPRESSION IN LEUKAEMIAS AND LYMPHOMAS WITH A NOVEL MONOCLONAL ANTIBODY, 2TL 242 (1996) (11)
Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124). (1996) (11)
Thymidine phosphorylase expression in normal and hyperplastic endometrium (2000) (11)
Cutaneous Diffuse Large B‐Cell Lymphoma, Leg Type (2010) (11)
Immunocytochemical analysis of cytocentrifuged fine needle aspirates. A study based on lung tumors aspirated in vitro. (1989) (11)
T‐helper cell lymphoma involving the lymph nodes and skin a clinical, morphologic, and immunohistochemical analysis of five cases (1985) (10)
p53 Overexpression in laryngeal squamous cell carcinoma and dysplasia (1995) (10)
JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues (2014) (10)
Immunocytochemistry in the detection of bone marrow metastases in patients with primary lung cancer. (1986) (10)
Reversible p53 expression in lung cancer (1992) (9)
Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas (2004) (9)
The prognostic significance of immunophenotype in high‐grade non‐Hodgkin's lymphoma (1989) (9)
An Illustrated Guide to Bone Marrow Diagnosis (1997) (9)
More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. (2000) (8)
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations☆ (2015) (8)
Measuring Proliferation In Routine Fine Needle Aspirates. Immunocytochemical Detection of Bromodeoxyuridine Incorporation and Ki‐67 Expression In Breast Aspirates (1992) (8)
Schistosomiasis-associated squamous lesions of the bladder. Expression of low molecular weight cytokeratin proteins. (1987) (8)
The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias. (1988) (8)
Twenty years after: the beautiful hypothesis and the ugly facts (2016) (8)
Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas (2004) (7)
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer (2017) (7)
Expression of Mutant p 53 in Melanoma 1 (2006) (7)
Handbook of immunohistochemistry and in situ hybridisation of human carcinomas: molecular genetics – lung and breast carcinomas (2005) (7)
Evidence Showing That Tumors Can Grow Without Angiogenesis and Can Switch Between Angiogenic and Nonangiogenic Phenotypes. (2016) (7)
Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer (2017) (7)
T‐Cell Large Granular Lymphocytic Leukaemia and Aggressive NK‐Cell Leukaemia (2011) (7)
Thymidine phosphorylase expression in Kaposi sarcoma. (1996) (7)
NPM-ALK gene fusion and Hodgkin's disease. (1997) (6)
Hodgkin’s Disease and So-Called Malignant Histiocytosis: (1984) (6)
The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-up. (1988) (6)
Blastic plasmacytoid dendritic cell neoplasm presenting as a renal mass (2011) (6)
bcl-2: Longevity Personified! (1997) (6)
EBM/11 reactivity in malignant histiocytosis. (1988) (6)
Comprar Skin Lymphoma: The Illustrated Guide | Kerl Helmut | 9781405185547 | Wiley (2009) (6)
B‐cell prolymphocytic leukaemia (2011) (6)
TRAP1 is Involved in Cell Cycle Regulated by Retinoblastoma Susceptibility Gene (RB1) in Early Hypoxia and has Variable Expression Patterns in Human Tumors (2013) (5)
Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer. (2014) (5)
Coexpression of MUC 1 Glycoprotein with Multiple Angiogenic Factors in Non-Small Cell Lung Cancer Suggests Coactivation of Angiogenic and Migration Pathways 1 (2000) (5)
The Diagnosis of Lymphoproliferative Diseases: An Atlas (2002) (5)
‘Follicular’ pattern of bone marrow involvement in lymphocyte‐predominant Hodgkin's disease (2003) (5)
Immunosuppression and thrombosis in renal transplantation: an immunohistological study (1990) (5)
Cytokeratin expression in smooth muscle and smooth muscle tumours. (1987) (5)
Intratumoral lactate dehydrogenase 5 (LDH5) protein expression is associated with expression of angiogenesis markers and hypoxia in patients with colorectal cancer (CRC) (2007) (4)
Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma. (1992) (4)
Other cutaneous B‐cell lymphomas (2010) (4)
Pulsed field gel electrophoresis on frozen tumour tissue sections. (1992) (4)
DETECTION OF p53 IN HODGKIN'S DISEASE USING THE MONOCLONAL ANTIBODY PAb248 (1996) (4)
Aggressive cutaneous cytotoxic lymphomas (2010) (3)
Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells. (1986) (3)
Cutaneous adult T‐cell leukemia/lymphoma (2010) (3)
Predictive Biomarkers and Personalized Medicine Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK 787 / ZK 222584 ( Vatalanib ) Antiangiogenic Therapy (2011) (3)
The Diagnosis of Lymphoproliferative Diseases: Gatter/The Diagnosis of Lymphoproliferative Diseases (2011) (3)
Angiogenesis in human lung tumours (2008) (3)
Cutaneous T-Cell Lymphomas (2004) (2)
Germline activating JAK2-mutation in a family with hereditary thrombocytosis (2012) (2)
Cutaneous Marginal Zone Lymphoma and Variants (2010) (2)
CD30+ Cutaneous Lymphoproliferative Disorders (2004) (2)
Immunocytochemical Analysis of Lymphoid Lesions Using -Fine Needle Aspiration Biopsy. (1990) (2)
An immunofluorescent study of the ampicillin rash (1982) (2)
Relationship of EBV and bcl‐2 in Hodgkin's disease (1995) (2)
Extranodal NK/T‐Cell Lymphomas: Nasal Type (2011) (2)
An unusual presentation of diffuse tenosynovial giant cell tumour in the neck (2003) (2)
An immunoelectron microscopic study of human placenta using three monoclonal antibodies. (1983) (2)
T‐Cell Lymphoblastic Lymphoma/Leukaemia (2011) (2)
bcl-2 immunoexpression in MALT-lymphomas. (1996) (2)
Malignant plasmacytosis mimicking erythrophagocytosis (2002) (2)
p53 expression in human tumours: breast, lung, colon, bladder and prostate cancer;melanoma and lymphoma. (1993) (2)
Cutaneous manifestations of B‐cell chronic lymphocytic leukemia (2010) (2)
V, Gatter KC, Harris AL, Koukourakis MI. Combined Role of Tumor Angiogenesis, bcl-2, and p53 Expression in the Prognosis of Patients With Colorectal Carcinoma. Cancer. 1999;86:1421-30 (2009) (2)
Cell Cycle and Senescence TRAP 1 Regulates Proliferation , Mitochondrial Function , and Has Prognostic Signi fi cance in NSCLC (2014) (1)
Pseudolymphomas of the skin (2010) (1)
Heterogeneity ofvascular endothelial cells with relevance todiagnosis ofvascular tumours (1992) (1)
The Antibody Revolution: How ‘Immuno’ Changed Pathology (2006) (1)
Therole ofimmunocytochemistry indiagnostic pathology (1987) (1)
Relationship of the Kras / cmos Expression Patterns With Angiogenesis in Non-Small Cell Lung Carcinomas (2001) (1)
Mature T and NK Cell Neoplasms (2014) (1)
Follicle Centre Cell Lymphoma (2004) (1)
Alveolar Soft Part Sarcoma: Ultrastructural and Immunohistological Studies with Monoclonal Antibodies (1984) (1)
Cytokeratin expression in smooth muscle and smooth muscle tumours. D. C. Brown, J. M. Theaker, P. M. Banks, K. C. Gatter & Mason D. Y. Histopathology 1987; 11; 477–486 (2002) (1)
Cutaneous lymphomas in immunosuppressed individuals (2010) (1)
839 Hypoxia-inducible factors 1a and 2a in skin malignant melanomas (2003) (1)
High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC) (2012) (1)
[Large cell anaplastic lymphomas in the immunocompromised host]. (1991) (1)
Inhibition Enhances Anti-VEGF Therapy Vivo In Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis (2012) (1)
Prognostic S ignificance o f a N ovel H ypoxia-Regulate d Marker, C arbonic A nhydrase I X, i n I nvasive B reast Carcinoma (2001) (1)
Cutaneous Hodgkin Lymphoma (2004) (1)
Immunocytochemistry as a diagnostic tool (1995) (1)
C. L. Oakley lecture (1989). Diagnostic immunocytochemistry: achievements and challenges. (1989) (1)
128 Genomic insights of ecg strain patten in aortic stenosis: t wave inversion and st-segment depression are underlined by different molecular pathways (2017) (1)
Cutaneous manifestations of myelogenous leukemia (2010) (1)
Comprar The Diagnosis Of Lymphoproliferative Diseases | Kevin Gatter | 9781405170147 | Wiley (2011) (1)
Mantle Cell Lymphoma (2011) (1)
Cutaneous manifestations of Hodgkin lymphoma (2010) (1)
The expression of phosphorylated KDR in haematological malignancies (2003) (0)
29. Histiocytic Sarcoma (2011) (0)
IMMUNOHISTOLOGICAL STUDY OF OSTEOCLASTS IN HUMAN-FETAL BONE (1986) (0)
Hispatopathology of Non-Hodgkin's Lymphomas, 2nd revised edition. Springer, Berlin (1992), 312, ISBN 3 540 51270 5 DM 248.00 (1993) (0)
Marginal Zone B‐Cell Lymphoma (Extranodal Malt and Nodal Types) and Extranodal Malt Lymphoma (2011) (0)
Langerhans Cell Histiocytosis (2011) (0)
Inducing angiogenesis a hallmark too far (2015) (0)
Patterns of expression of three hypoxia regulated proteins (Hypoxia Inducible Factors HIF1a/HIF1b and Carbonic Anhydrase (CA9) in squamous cell lung carcinoma (2001) (0)
Other Cutaneous Lymphomas/Leukaemias (2004) (0)
Humanlung tumours may coexpressdifferent classes ofintermediate filaments (1986) (0)
Kidney Liver * Lung Adrenal Thyroid Ovary Testis Skin Lymph node Tonsil Thymus Spleen Cerebrum and cerebellum Pancreas Glomerular capillaries Interstitial capillaries (2004) (0)
Peripheral T Cell Lymphomas, Unspecified (2006) (0)
DNA AND RNA STUDIES INTO THE NPM-ALK REARRANGEMENT IN KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA, DIAGNOSTIC APPLICATIONS (1994) (0)
Newapproach toassessing lung tumoursinman (1986) (0)
Human Immunodeficiency Virus Infection (2006) (0)
Prognosis of Patients Correlated with Markers of Hypoxia / Acidity and with Poor Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Enhanced Expression of SPARC / Osteonectin in the Updated Version (2003) (0)
BOOK REVIEW An Illustrated Guide to Skin Lymphoma: Second Edition (2007) (0)
Marginal Zone B Cell Lymphoma (Including Malt Type) (2006) (0)
Differential expression ofthetopoisomerase llaandfigenes inhuman breast cancers (1996) (0)
IMMUNOCYTOCHEMICAL STUDY OF THE BCL-2 GENE-PRODUCT (1990) (0)
Hepatosplenic T‐Cell Lymphoma (2011) (0)
Histone Demethylase JMJD2B Is Regulated by Estrogen (2010) (0)
Abstract B25: Autocrine action of VEGF/VEGFR pathway in human Glioblastomas in addition to the paracrine angiogenic role (2010) (0)
Cutaneous Lymphomas in Immunosuppressed Individuals (Post-Transplant Lymphoproliferative Disorders, HIV-Associated Cutaneous Lymphomas) (2004) (0)
15. Burkitt Lymphoma (2011) (0)
Anaemias and Aplasias (2006) (0)
Vascular endothelial growth factor expression in lung cancer. (1998) (0)
Cutaneous manifestations of other leukemias (2010) (0)
Expression of VEGF, its receptors and hypoxia inducible factors in acute myeloblastic leukaemia (2005) (0)
Expression ofintermediate filament proteins in normal anddiseased thyroid glands (1987) (0)
Expression of proline-hydroxylated HIF-1α predicts poorer overall survival in primary breast cancer. (2014) (0)
bcl-2, Epstein-Barr virus-latent membrane protein, EBNA-1, and EBNA-2 staining in posttransplantation lymphoproliferative disorders. (1996) (0)
Phosphorylated KDR expression in acute leukaemia. (2002) (0)
Mature B Cell Neoplasms (2014) (0)
Subcutaneous Panniculitis‐Like T‐Cell Lymphoma and Primary Cutaneous γ/δ T‐Cell Lymphoma (2011) (0)
Diagnostic histopathology of the lymph node. James A. Strauchen. Oxford University Press, New York, 1998 (1999) (0)
Crypt Cell Proliferation (CCP) Hla-Dr Expression and Intra Epithelial Lymphocytes (IEL) in Pelvic Ileal Pouches (1990) (0)
inapparently normal bonemarrow trephine specimens frompatients withnodalfollicular lymphoma (1995) (0)
Ten-year follow up case-control study of the effect of portal vein embolisation on the survival of patients with colorectal liver metastases; the hypoxia factor influence (2016) (0)
The biological and clinical significance of different morphologic types of colorectal liver metastases (2014) (0)
Expression of PHD (prolyl hydroxylase)-1, PHD-2 and PHD3 is upregulated in the nucleus and cytoplasm in neoplastic breast disease and nuclear PHD expression is associated with the estrogen receptor in invasive breast carcinomas (2005) (0)
Cutaneous Small–Medium Pleomorphic T‐Cell Lymphoma (2010) (0)
The cutaneous “atypical lymphoid proliferation” (2010) (0)
Hairy Cell Leukaemia (2011) (0)
Bone, Stroma and Miscellaneous Changes (2014) (0)
2027 Up-regulation of angiogenesis and of the angiogenic factor thymidine phosphorylase is involved in cancer regeneration during radiotherapy for head and neck cancer: Implications in the therapeutic outcome (1999) (0)
Enteropathy‐Associated T‐Cell Lymphoma (2011) (0)
Human herpes virus 8 (HHV8) localisation in Castleman's disease raises important questions in relation to disease pathogenesis (1997) (0)
Atrial fibrillation, fibrosis, and hypoxia (2004) (0)
Myeloid Leukaemias (Myeloid Sarcoma) (2011) (0)
An Immunohistological Study of Skin Tumours (1984) (0)
Infections Including Human Immunodeficiency Virus (2014) (0)
Phosphorylated VEGFR-2 (pVEFGR-2/pKDR) is over-expressed in and translocates to the nucleus in acute leukemias: Analyses using a novel pKDR antibody. (2003) (0)
Expression of Mutant p 53 in Melanoma Updated (2006) (0)
The Myelodysplastic Syndromes (2006) (0)
DETECTING t(14;18) IN PARAFFIN-EMBEDDED LYMPHOMA TISSUE (1989) (0)
IMMUNOHISTOLOGICAL STUDY OF OSTEOCLASTS AND MULTINUCLEATE CELLS OF GIANT-CELL TUMOR OF BONE (1985) (0)
Original Article Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer (2014) (0)
B‐Cell Lymphoblastic Leukaemia/Lymphoma (2011) (0)
Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (2006) (0)
detection ofp53and Bcl-2 proteinsinHashimoto's thyroiditis and primary thyroid lymphomas (1995) (0)
The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy. (2003) (0)
Immunocytochemical characterisation ofcutaneous lymphomas other thanmycosis fungoides (1986) (0)
Angioimmunoblastic T‐Cell Lymphoma (2011) (0)
Peripheral T‐Cell Lymphoma (2011) (0)
Mycosis Fungoides/Sézary Syndrome (2011) (0)
9. Lymphoplasmacytic Lymphoma (2011) (0)
Monoclonal antibodies in diagnostic immunohistochemistry. M. R. Wick and G. P. Siegal (Eds). Marcel Dekker, New York, 1988. No. of pages: x+654. ISBN: 0 8247 7838 3 (1988) (0)
Small-medium Pleomorphic T-Cell Lymphoma (2004) (0)
Large Granular Lymphocyte Leukemia (2006) (0)
Cutaneous follicle center lymphoma (2010) (0)
Follicular Dendritic Cell Proliferations and Related Entities (2011) (0)
Expert Commentary. (2002) (0)
Reactive and Infective Conditions (2011) (0)
Focal expression of platelet-derlved endothelial cell growth factor (PD-ECGF)triggers local neo-angiogenesls in non-small cell lung cancer (1997) (0)
Corrigendum (2009) (0)
Blastic NK-Cell Lymphoma (2004) (0)
Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer (2007) (0)
Immunohistochemistry ofcytokeratin proteins in squamousandtransitional celllesions oftheurinary tract (1988) (0)
Lymphoplasmacytic Lymphoma (Including Waldenström Macroglobulinemia) (2006) (0)
327 POSTER Expression of intratumoral lactate dehydrogenase 5 (LDH5) and expression of biomarkers for angiogenesis and hypoxia are linked in patients with colorectal cancer (CRC) (2007) (0)
Vascularity in Human Breast Cancer Relationship of Endothelial Cell Proliferation to Tumor (2006) (0)
The Value of Immunocytocherniistry in Differentiating HiLgh-Grade: Lymphoma from 0 ther Anaplastic (1989) (0)
EBNA expression in Reed-Sternberg like cells in post-transplant lymphoproliferative disorders. (1996) (0)
130 The convergence and divergence of molecular pathways in lv hypertrophy defined by ecg voltage versus lv mass in patients with aortic stenosis (2017) (0)
TAL1 gene deletions and TAL1 protein expression in sporadic melanoma (1995) (0)
[Malignant lymphomas expressing an epithelial membrane antigen. Value in the immunohistochemical diagnosis of tumors]. (1985) (0)
EBM/11reactivity inmalignant histiocytosis (1988) (0)
Angiogenesis in lung cancer (1999) (0)
Use of bronchial brushings in the immunocytochemical assessment of human lung tumors. (1988) (0)
VS38:anewmonoclonal antibody fordetecting plasma cell differentiation inroutine sections (2017) (0)
Lymphangiogenesis in Squamous Cell Carcinoma of the Head and Neck Revealed with Antibodies to a New Lymphatic Marker, LYVE-1 (2000) (0)
The Angiogenesis Regulator & Notch Pathway Activator Delta like Ligand 4 (DI14) Is Widely Expressed by Vascular & Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study (2009) (0)
Marginal Zone Lymphoma and Cutaneous Immunocytoma (2004) (0)
Primary Cutaneous CD30+ Lymphoproliferative Disorders (2010) (0)
The second K Prathap memorial lecture. Cancer of the lung: an immunocytochemical, histological and ultrastructural study. (1987) (0)
The Diagnosis of Lymphoproliferative Diseases: Second Edition (2011) (0)
7103 Baseline and on-treatment expression of HIF-1a, HIF-2a and CAIX in patients with metastatic renal cell carcinoma (2009) (0)
Monoclonal antibody Leu-22. (1990) (0)
Comparison ofproliferation ratesassessed using "multiblock" andconventional tissue blocks of lungcarcinoma (1992) (0)
Chronic Lymphocytic Leukemia (2006) (0)
Blastic Plasmacytoid Dendritic Cell Neoplasm (CD4+/CD56+Hematodermic Neoplasm) (2010) (0)
Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival (2011) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
routine sections . detecting plasma cell differentiation in VS 38 : a new monoclonal antibody for (0)
Loss of TRAP1 expression as a possible mechanism behind recurrence risk in advanced breast cancer (2011) (0)
Other Cutaneous Cytotoxic Lymphomas (2004) (0)
Precursor B and T Lymphoblastic Leukaemia (Acute Lymphoblastic Leukaemia) and Lymphoblastic Lymphoma (2014) (0)
primary thyroid lymphomas . Bcl-2 proteins in Hashimoto ' s thyroiditis and Immunohistochemical detection of p 53 and (0)
Expression of Hypoxia-inducible Factors in Human Renal Cancer : Relationship to Angiogenesis and to the von Hippel-Lindau Gene Mutation 1 (2002) (0)
Expression of Mutant p53 in Melanoma1 (2006) (0)
Subcutaneous T-Cell Lymphoma (2004) (0)
The Normal Bone Marrow (2006) (0)
Lymphomas: an Overview (2014) (0)
CD68reactivity ofnon-macrophage derived tumours incytological specimens (1993) (0)
Cutaneous Myelogenous Leukaemia (2004) (0)
Adult T‐Cell Lymphoma/Leukaemia (2011) (0)
Hairy Cell Leukemia (2006) (0)
Immunodeficiency‐Associated Lymphoproliferative Disorders (2011) (0)
Cancer biology through immunohistology (2019) (0)
B-Lymphoblastic Lymphoma (2004) (0)
An Introduction to Lymphoma Diagnosis (2011) (0)
Endothelial cell proliferation in human breast carcinoma (1993) (0)
Apoptosis as predictive factor for cancer therapy (1996) (0)
Cutaneous lymphoblastic lymphomas (2010) (0)
Cancer and metabolism (1964) (0)
Correspondence (1989) (0)
Miscellaneous conditions in the bone marrow (2002) (0)

This paper list is powered by the following services:

Other Resources About Kevin Gatter

en.wikipedia.org

What Schools Are Affiliated With Kevin Gatter?

Kevin Gatter is affiliated with the following schools: